Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis

Investigator: Nisha Acharya, MD
Sponsor: Alcon, Inc.

Location(s): United States


The purpose of this study was to demonstrate that difluprednate 0.05% (Durezol) dosed 4 times daily is noninferior to prednisolone 1% (Pred Forte) dosed 8 times daily for the treatment of endogenous anterior uveitis.